…
|
Read more http://www.grants.gov/web/grants/view-opportunity.html?oppId=166853
…
|
Read more http://www.grants.gov/web/grants/view-opportunity.html?oppId=166853
…
|
Read more http://www.grants.gov/web/grants/view-opportunity.html?oppId=160034
Something as mundane and common as giving and receiving compliments may be a serious challenge if you are an immigrant.
Over the years, I have learned, often the hard way, the essential importance of receiving and giving compliments, at home, at work, and in social or semi-social environment. Generally speaking, East Asian cultures tend to be more reserved in expressing appreciations or affection toward others compared to the American culture (some generalization here). We have all heard of such jokes about Asian parents singling out the only “B” in the child’s report card amidst all other “A”s and demand to know why the child had failed to get straight “A”s, while American-born parents would emphasize on the progress or efforts rather than the outcome.
Health IT groups and mobile application developers’ reaction to FDA’s release of final guidance for mobile health apps is mixed, the Baltimore Sun reports (Wells/Clarke, Baltimore Sun, 9/23).
Details of Final Rule
According to the final guidance issued Monday, FDA will focus oversight on apps that:
The United States Food and Drug Administration has finally released guidelines on how it plans to regulate thousands of new health-related smartphone applications.
After months of delaying its decision, the agency has determined that the vast majority of these health-related apps pose a negligible threat to consumers. Most of these “mobile medical” apps do not need federal regulation, the FDA found, so developers and investors can breathe a bit easier.
Wednesday, October 30, 2013
8:30 AM to 11:30 AM
Do you love health technology? Do you want to learn more about it? Do you want to teach others and collaborate with local experts?
Call it what you want–mobile health, digital health, health IT–it’s all about using innovative technology to improve the lives of you, me, and the people we care about. Let’s build an ecosystem dedicated to making health technology part of everyday life and the standard of care! Being located in the Maryland area, we have all the pieces to the puzzle to promote innovation, collaboration, and investment in an industry that will revolutionize healthcare and impact the lives of all 7+ billion people around the world.
Join our ecosystem for the MD HealthTech Coalition Kickoff Event and hear from a panel of experts about the challenges, opportunities, and innovative solutions. More details to follow…
How can you tell Maryland is becoming a hotbed for cyber security business?
Ellen J. Hemmerly said it’s obvious from the companies looking into University of Maryland, Baltimore County’s technology incubator.
“We’re attracting not only local and regional entrepreneurs,” Hemmerly said. “We’re getting more and more inquiries and tenants from out of state.”
Montgomery County’s largest biotechnology company, which is celebrating its 25th anniversary this week, actually hatched from a meeting in the Big Apple.
In the late 1980s, Wayne T. Hockmeyer was an executive with Praxis Biologics in Rochester, N.Y., with an inkling to branch out on his own. He had spent two decades in the U.S. Army, including as chairman of the Department of Immunology at Walter Reed Army Institute of Research in Washington, D.C., from 1980 to 1986.
The state’s two major research institutions, Johns Hopkins University and the University of Maryland, College Park , are partnering to build a research and science center in East Baltimore opening September 2014. The state is spending $27 million and Hopkins is contributing $3 million toward the $30 million public/private venture whose goal is to make Maryland’s universities and private industry more competitive in the sciences.
The High Performance Research Computing Facility will consist of multiple buildings on land leased from Hopkins on its 350-acre Bayview Medical campus, at 4940 Eastern Ave. Expected to break ground in November, the center will be set off from other buildings and have its own separate entrance. The universities will finish site design this month and then bid the project to vendors.
GlaxoSmithKline announced on Thursday that it has signed a four-year contract with the Biomedical Advanced Research and Development Authority for the provision of its inhalation anthrax treatment, raxibacumab.
In the new contract, GSK will give the United States government 60,000 doses of raxibacumab over a four year period. The estimated value of these shipments total $196 million.